{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T06:03:10Z","timestamp":1733896990027,"version":"3.30.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03643-4","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T11:14:24Z","timestamp":1733742864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Erythema Elevatum diutinum \u2013 a long-term case series of 10 patients"],"prefix":"10.1007","volume":"317","author":[{"given":"Marielos I.","family":"Posada Posada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Beatrice","family":"Alora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinaida Taligare Vasconcelos","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"issue":"12","key":"3643_CR1","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/jdv.12566","volume":"28","author":"SE Momen","year":"2014","unstructured":"Momen SE, Jorizzo J, Al-Niaimi F (2014) Erythema Elevatum diutinum: a review of presentation and treatment. J Eur Acad Dermatol Venereol 28(12):1594\u20131602. https:\/\/doi.org\/10.1111\/jdv.12566","journal-title":"J Eur Acad Dermatol Venereol"},{"doi-asserted-by":"crossref","unstructured":"Chen ML, Chlopik A, Hoang MP, Smith GP (2017) Complete resolution of erythema elevatum diutinum using oral sulfasalazine. Dermatol Online J 23(10):13030\/qt8267v8v9. Published 2017 Oct 15","key":"3643_CR2","DOI":"10.5070\/D32310037013"},{"issue":"4","key":"3643_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1067\/s0190-9622(03)01834-6","volume":"49","author":"WA High","year":"2003","unstructured":"High WA, Hoang MP, Stevens K, Cockerell CJ (2003) Late-stage nodular erythema elevatum diutinum. J Am Acad Dermatol 49(4):764\u2013767. https:\/\/doi.org\/10.1067\/s0190-9622(03)01834-6","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3643_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijwd.2020.01.009","volume":"6","author":"S Mushtaq","year":"2020","unstructured":"Mushtaq S, Sarkar R (2020) Sulfasalazine in dermatology: a lesser explored drug with broad therapeutic potential. Int J Womens Dermatol 6(3):191\u2013198. https:\/\/doi.org\/10.1016\/j.ijwd.2020.01.009","journal-title":"Int J Womens Dermatol"},{"issue":"5","key":"3643_CR5","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1111\/ijd.13542","volume":"56","author":"SL Bevans","year":"2017","unstructured":"Bevans SL, Sami N (2017) Dapsone and sulfasalazine combination therapy in dermatitis herpetiformis. Int J Dermatol 56(5):e90\u2013e92. https:\/\/doi.org\/10.1111\/ijd.13542","journal-title":"Int J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03643-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T03:19:52Z","timestamp":1733887192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03643-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3643"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03643-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Xinaida Taligare V. Lima, M.D., is a clinical investigator for Amgen, Biogen and Janssen. She is on the speaker\u2019s bureau of Abbvie, Boehringer, Janssen and Novartis and a consultant for UCB Biopharma. Maria Beatrice Alora, M.D., is a clinical investigator for Pfizer, Inc. Abbvie, Concert Pharmaceuticals, Sanofi, Eli Lilly and Janssen. Marielos I. Posada Posada has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"88"}}